Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Environ Res ; 257: 119296, 2024 Sep 15.
Article in English | MEDLINE | ID: mdl-38824985

ABSTRACT

As the rapidly growing number of waste lithium-ion batteries (LIBs), the recycling and reutilization of anode graphite is of increasing interest. Converting waste anode graphite into functional materials may be a sensible option. Herein, a series of carbonaceous catalysts (TG) were successfully prepared using spent anode graphite calcined at various temperatures and applied for activating peroxymonosulfate (PMS) to degrade atrazine (ATZ). The catalyst obtained at 800 °C (TG-800) showed the optimum performance for ATZ removal (99.2% in 6 min). Various experimental conditions were explored to achieve the optimum efficiency of the system. In the TG-800/PMS system, free radicals (e.g., SO4·-, HO·), singlet oxygen (1O2), together with a direct electron transfer pathway all participated in ATZ degradation, and the ketonic (CO) group was proved as the leading catalytic site for PMS activation. The potential degradation routes of ATZ have also been presented. According to the toxicity assessment experiments, the toxicity of the intermediate products decreased. The reusability and universal applicability of the TG-800 were also confirmed. This research not only provides an efficient PMS activator for pollutant degradation, but also offers a meaningful reference for the recovery of waste anode graphite to develop environmentally functional materials.


Subject(s)
Atrazine , Electrodes , Graphite , Peroxides , Atrazine/chemistry , Graphite/chemistry , Peroxides/chemistry , Catalysis , Water Pollutants, Chemical/chemistry , Water Pollutants, Chemical/analysis , Herbicides/chemistry
2.
Environ Sci Pollut Res Int ; 29(32): 49322-49334, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35220532

ABSTRACT

In this study, discarded mushroom-stick, which is widely available, was selected as a precursor to prepare MnO2-modified biochar (MBC) for Sb(III) removal. Several characterisation methods (SEM, BET, XPS, FT-IR, and XRD) were used to explore the mechanisms of antimony adsorption onto MBC. The results showed that MBC is a mesoporous material with a fluffy structure and a higher specific surface area (23.56 and 32.09 m2·g-1) than PBC600 (13.62 m2·g-1), exhibiting superior and stable adsorption capacities for Sb(III) (50.30 mg·g-1 for 1/30MBC600 and 64·12 mg·g-1 for 1/20MBC600) across a wide pH range (pH 4-8). X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared (FT-IR) spectroscopy analyses indicated that the main oxides and functional groups involved in the adsorption were manganese oxides and hydroxyl groups. Forty-four per cent of the adsorbed Sb(III) was oxidised to Sb(V) by manganese oxides or hydroxyl groups both on the surface of biochar and in solution. According to adsorption kinetics and isotherms, the adsorption process of Sb(III) is chemisorption, which includes monolayer and multilayer heterogeneous chemisorption processes. To sum up, MBC is an excellent adsorbent for the capture of Sb(III) from contaminated water with strong potential for future application.


Subject(s)
Agaricales , Water Pollutants, Chemical , Adsorption , Charcoal/chemistry , Hydrogen-Ion Concentration , Kinetics , Manganese , Manganese Compounds/chemistry , Oxides/chemistry , Spectroscopy, Fourier Transform Infrared , Water , Water Pollutants, Chemical/chemistry
3.
J Interferon Cytokine Res ; 39(8): 495-505, 2019 08.
Article in English | MEDLINE | ID: mdl-31074668

ABSTRACT

The study was conducted to investigate the protective effects of Salvia miltiorrhiza polysaccharides (SMPs) on lipopolysaccharides (LPS)/d-galactosamine (d-GalN)-induced liver injury in mice and its mechanism. Seventy-two mice were allocated to 6 groups of 12 each, that is, the untreated control group, the liver injury model group, the Bifendate group (Bifendate 200 mg/kg/day), and 3 SMP-treated groups at low (250 mg/kg/day), medium (500 mg/kg/day), and high doses (750 mg/kg/day). After 12 days oral treatment, liver injury was induced with LPS/d-GalN, and 1 h later the mice were sacrificed for a series of analyses. The results showed that SMPs significantly alleviated pathological changes in the hepatic tissue. Compared with the untreated control group, the messenger RNA (mRNA) levels of lipopolysaccharide-binding protein (LBP), cluster of differentiation 14 (CD14), myeloid differentiation factor 2 (MD-2), toll-like receptor 4 (TLR4), and myeloid differentiation primary response protein 88 (MyD88) detected by quantitative real-time polymerase chain reaction (qRT-PCR), the protein levels of TLR4, MyD88, phosphorylated inhibitor of nuclear factor kappa-B kinase alpha/beta (P-IKK-α/ß), phosphorylated inhibitor of NF-κB alpha (P-IκB-α) and phosphorylated P65 (P-P65) detected by Western blot, the levels of C-X-C motif chemokine 10 (CXCL-10) and Intercellular Adhesion Molecule 1 (ICAM-1) detected by immunohistochemistry, and the concentrations of tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1ß) detected by enzyme-linked immunosorbent assay of liver injury model group were increased significantly (P < 0.01). Compared with liver injury model group, the mRNA levels of LBP, CD14, MD-2, TLR4, and MyD88; protein levels of TLR4, MyD88, P-IKK-α/ß, P-IκB-α, and P-P65; levels of CXCL-10 and ICAM-1; and the concentrations of TNF-α and IL-1ß of SMP groups and Bifendate group were decreased significantly (P < 0.01 or P < 0.05). In conclusion, SMPs can effectively inhibit TLR4/MyD88 inflammatory signaling pathway of LPS/d-GalN-induced liver injury in mice, and it may be part of the mechanism by which SMPs relieve excessive inflammation in the liver of mice.


Subject(s)
Chemical and Drug Induced Liver Injury/drug therapy , Myeloid Differentiation Factor 88/antagonists & inhibitors , Polysaccharides/pharmacology , Protective Agents/pharmacology , Salvia miltiorrhiza/chemistry , Signal Transduction/drug effects , Toll-Like Receptor 4/antagonists & inhibitors , Administration, Oral , Animals , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Disease Models, Animal , Galactosamine , Male , Mice , Mice, Inbred Strains , Myeloid Differentiation Factor 88/genetics , Myeloid Differentiation Factor 88/metabolism , Polysaccharides/administration & dosage , Protective Agents/administration & dosage , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/metabolism
4.
Bull Econ Res ; 63(1): 1-27, 2011.
Article in English | MEDLINE | ID: mdl-21141646

ABSTRACT

Medicare's prospective payment system for hospitals (PPS), introduced in the USA in 1983, replaced cost reimbursement with a system of fixed rates which created incentives for hospitals to control costs. Previous studies found that elderly patients were discharged from hospital "quicker and sicker" under PPS and concluded that families were coping at home. We analyse a national longitudinal survey, the first National Health and Nutrition Examination Survey and its Epidemiologic Followup Study, which includes data on more outcomes over a longer period than earlier studies. We find that the rate of admission to nursing homes from the community in the first weeks after a hospital discharge more than tripled under PPS, suggesting that families were not always able to cope. As another response to sicker patients, discharges directly to nursing homes from hospitals, which jumped initially under PPS, may have risen further when payment rates were tightened in the early 1990s. Hospital readmissions fell after the first few years. Our findings are strengthened by the fact that we control for patients' health using health information collected independently of hospital admission.


Subject(s)
Hospitals , Medicare , Nursing Homes , Nutrition Surveys , Patient Readmission , Prospective Payment System , Adaptation, Psychological , Delivery of Health Care/economics , Delivery of Health Care/ethnology , Delivery of Health Care/history , Delivery of Health Care/legislation & jurisprudence , Government Programs/economics , Government Programs/education , Government Programs/history , Government Programs/legislation & jurisprudence , Health Care Costs/history , Health Care Costs/legislation & jurisprudence , History, 20th Century , Hospitals/history , Medicare/economics , Medicare/history , Medicare/legislation & jurisprudence , Nursing Homes/economics , Nursing Homes/history , Nursing Homes/legislation & jurisprudence , Nutrition Surveys/economics , Nutrition Surveys/history , Nutrition Surveys/legislation & jurisprudence , Patient Discharge/economics , Patient Discharge/legislation & jurisprudence , Patient Readmission/economics , Patient Readmission/legislation & jurisprudence , Prospective Payment System/economics , Prospective Payment System/history , Prospective Payment System/legislation & jurisprudence , United States/ethnology
SELECTION OF CITATIONS
SEARCH DETAIL
...